FDA Adverse Event Malfunction Summary report: N

I-STAT EG7+ CARTRIDGE

MDR report key: 10635224 · Received October 6, 2020

Report

Report Number
2245578-2020-00108
Event Type
Malfunction
Date Received
October 6, 2020
Date of Event
September 28, 2020
Report Date
December 2, 2020
Manufacturer
ABBOTT POINT OF CARE
Product Code
CHL
UDI-DI
10054749000040
PMA / PMN Number
K940918
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SN
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

APOC INCIDENT: (B)(4). THE INVESTIGATION WAS COMPLETED ON (B)(6) 2020. A REVIEW OF THE DEVICE HISTORY RECORD (DHR) CONFIRMED THE CARTRIDGE LOT MET FINISHED GOODS (FG) RELEASE CRITERIA. RETAIN TESTING MET THE ACCEPTANCE CRITERIA FOUND IN Q04.01.003 REV. AF, APPENDIX 1 - PRODUCT COMPLAINT LEVEL 2 AND LEVEL 3 INVESTIGATION PROCEDURE. NO DEFICIENCY HAS BEEN DETERMINED FOR EG7+ LOT N20193.

Additional Manufacturer Narrative · 1

APOC INCIDENT # (B)(4). APOC LABELING WILL BE EVALUATED DURING THE INVESTIGATION AS PERTAINING TO THE EVENT.

Description of Event or Problem · 1

ON (B)(6) 2020, ABBOTT POINT OF CARE WAS CONTACTED BY A CUSTOMER REGARDING I-STAT EG7+ CARTRIDGES THAT YIELDED A SUSPECTED DESCREPANT HEMOGLOBIN RESULT OF 23.5 G/DL ON A PATIENT THERE WAS NO PATIENT INFORMATION AVAILABLE AT THE TIME OF THIS REPORT. THE CUSTOMER HAS NOT RESPONDED TO MULTIPLE ATTEMPTS FOR INFORMATION. RETURN PRODUCT IS NOT AVAILABLE FOR INVESTIGATION. METHOD: DATE: TESTED: RESULT (UNITS) : LAB: (B)(6) 2020; 13:10; 9.1 G/DL. I-STAT: (B)(6) 2020; 14:01; 10.5 G/DL. I-STAT: (B)(6) 2020; N14:46; 23.5 G/DL. I-STAT: (B)(6) 2020; 22.00; 7.8 G/DL. AT THIS TIME, THERE IS NO REASON TO SUSPECT A MALFUNCTION EXISTS. THE REPORTING DECISION WAS BASED ON INFORMATION AVAILABLE THAT SUGGESTS THE PRODUCT WAS NOT PERFORMING WITHIN THE VARIABILITY OF THE ASSAY. THE INVESTIGATION IS UNDERWAY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1103392 I-STAT EG7+ CARTRIDGE EG7+ CARTRIDGE CHL ABBOTT POINT OF CARE NA N20193 10054749000040

Patients

Seq Age Sex Outcome Treatment
1